JV-1-36 acetate

• CAT Number: I040036
• Molecular Formula: C172H284ClN53O41.xC2H4O2
• Molecular Weight: 3785.88 (free base)
• Purity: ≥95%

JV-1-36 Acetate (Cat No.: I040036) is a potent growth hormone-releasing hormone (GHRH) antagonist with applications in endocrinology and cancer research. It inhibits GHRH signaling, reducing growth hormone secretion and influencing tumor growth in hormone-dependent cancers. This peptide is widely used in studies related to metabolic disorders, cancer progression, and neuroendocrine regulation. The acetate form enhances its stability and solubility for in vitro and in vivo applications, making JV-1-36 Acetate a valuable tool in developing novel therapeutic strategies for endocrine and oncological diseases.

Reference

[1]. Kubra KT, et al. Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells. Endocrines. 2022 Dec;3(4):813-820.
[Content Brief]